Global Allergy & Airways Patient Platform

GAAPP represents more than 150 organizations working to improve the quality of life of people who have #allergies, #airways, or #atopic diseases world-wide.

[Global Allergy & Airways Patient Platform @gaapporg]

A new resource is available to help you discuss long-term asthma goals with patients. Clinical remission offers a framework to measure success beyond symptom control.
Download our new infographic to support shared decision-making: https://t.co/5GQrpLp1mK

[Global Allergy & Airways Patient Platform @gaapporg]

#GAAPPAcademy: Learn how empowering youth in decision-making roles can impact your patient organization’s sustainability with Vincent Mugwati (Medical Student & Youth Leader, Rare Diseases Intl.)
📅 25 August | ⏰ 15:00 CEST
Register here: https://t.co/lgySD7GX6o

[Global Allergy & Airways Patient Platform @gaapporg]

GAAPP member Territorio Salud & Universidad Complutense de Madrid launch the "Expert in Chronic Care & Child Welfare Coordinator" program for educators, nurses, trainers. Starts 13 Oct. 35 spots. In Spanish only. Enroll: https://t.co/cn9dmfyf7Y
#SupportedbyGAAPP

[Global Allergy & Airways Patient Platform @gaapporg]

When it comes to #COPD, understanding is key to better management & QoL. The COPD Success Group's new peer-reviewed guide for patients & families is here—from diagnosis to daily care. Download FREE: https://t.co/8q887fyNlN

[Global Allergy & Airways Patient Platform @gaapporg]

Our new infographic on Clinical Remission in Asthma covers:
✅ The 4 key criteria for remission.
✅ What remission does and does not mean.
✅ Conversation starters to empower patients to articulate their goals.
Discuss it with your patients: https://t.co/5GQrpLp1mK

[Global Allergy & Airways Patient Platform @gaapporg]

"Measure the health dividend, not just costs," GAAPP told 60+ nations at #UNITE2026. But Pres. Tonya Winders shares a deeper lesson from Manila: Kapwa—seeing our shared humanity. Breakthroughs begin with connection, not policy.

[Global Allergy & Airways Patient Platform @gaapporg]

#GAAPPAcademy: Learn how empowering youth in decision-making roles can impact your patient organization’s sustainability with Vincent Mugwati (Medical Student & Youth Leader, Rare Diseases Intl.)
📅 25 August | ⏰ 15:00 CEST
Register here: https://t.co/lgySD7GX6o

[Global Allergy & Airways Patient Platform @gaapporg]

Nominations are now open for the GAAPP Board of Directors. We're looking for leaders to represent Latin America, Africa & the Middle East, and Asia-Pacific. Submit your nomination by 21 Aug on https://t.co/B6QsFlJuK5

[Global Allergy & Airways Patient Platform @gaapporg]

That's a wrap on #AMEA2026 in Nairobi! 🇰🇪 22 orgs, 11 countries, one shared mission. Key takeaway from our executive panel today: "Lived experience is practical evidence for better care." Feedback from our members: "I return inspired to do more for our patient community."

[Global Allergy & Airways Patient Platform @gaapporg]

Member appreciation: AAPDA from Puerto Rico provided 436 appointments with dermatologists, PCPs + screenings, vaccinations in one day!🤯
✅ Help people with skin conditions in PR thrive! Donate today to support AAPDA's next initiative: https://t.co/Sx5nTV9B09
#SupportedbyGAAPP

[Global Allergy & Airways Patient Platform @gaapporg]

Day 1 of the #AMEA2026 Regional Meeting in Nairobi is in the books! 22 orgs, 11 countries, big conversations on sustainability, collaboration & advocacy. 🇰🇪
"Day one set a remarkably high standard."
— Member Harry Koroma
Day 2: policy & workshops ahead! Stay tuned.

[Global Allergy & Airways Patient Platform @gaapporg]

We’re bringing together over 25 GAAPP #AMEA2026 (Africa & Middle East Alliance) members for our 2026 Regional Meeting in Nairobi to tackle issues in respiratory immunology care, all under the banner of "Together for Health. Stand with Science." Updates? 👉https://t.co/CuOXBzm0HT.

[Global Allergy & Airways Patient Platform @gaapporg]

Sign up now to share your voice at #LetsTalkCough, an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on 28 Oct, where people affected by chronic cough can share their experiences directly with the FDA & researchers. 🔗 Register: https://t.co/pRUYrT9UXO

[Global Allergy & Airways Patient Platform @gaapporg]

When it comes to #COPD, understanding is key to better management & QoL. The COPD Success Group coalition's new peer-reviewed guide for patients & families is here—from diagnosis to daily care. Download FREE: https://t.co/C8sVbdP5Lu

[Global Allergy & Airways Patient Platform @gaapporg]

Olfactory & gustatory dysfunctions are profound indicators of severe tissue inflammation. Help your allergic fungal rhinosinusitis patients stop guessing if it's AFRS and start tracking it. Download and print the My AFRS Visit Card tracker: https://t.co/iyw9uKf2Qi #TrackYourAFRS

[Global Allergy & Airways Patient Platform @gaapporg]

Today we stand w/ our partners at NTM Info & Research for #WorldNTMAwarenessDay. Nontuberculous mycobacteria is a lung condition that is often misdiagnosed—especially in patients w/ bronchiectasis, COPD & asthma. Our goal: earlier testing, better care, and practical support.

[Global Allergy & Airways Patient Platform @gaapporg]

Help allergic fungal rhinosinusitis patients recognize patterns and prepare for consultations with the new My AFRS Visit Card—featuring targeted doctor questions and an easy symptom tracker. Learn more on https://t.co/iyw9uKf2Qi #TrackYourAFRS

[Global Allergy & Airways Patient Platform @gaapporg]

The GINA‑integrated #ChronicAirwaysAssessmentTest (CAAT) is a standardized, patient‑centered health assessment tool that includes questions about sputum and energy levels.
🔗 https://t.co/i1pW46ppZY
🔗 Access the CAAT Tool: https://t.co/9W7Y5V5IYN

[Global Allergy & Airways Patient Platform @gaapporg]

Identifying unique symptom profiles is essential for an accurate sinus diagnosis. Help patients stop guessing if it’s allergic fungal rhinosinusitis and start tracking it before their next appointment using our brand-new My AFRS Visit Card: https://t.co/iyw9uKf2Qi #TrackYourAFRS

[Global Allergy & Airways Patient Platform @gaapporg]

Constantly treating sinus issues without finding real relief? AFRS isn't a simple infection—it's an immune reaction to airborne fungi. Swipe through to learn how AFRS differs from standard sinusitis & grab our free My AFRS Visit Card: https://t.co/iyw9uKf2Qi #TrackYourAFRS